業績

2020年 研究・実績

英論文

Ⅰ.著書（単行本・分担執筆）
Ⅱ.原著・総説
  1. Ozawa Y, Yamamoto H, Yasuo M, Komatsu M, Ushiki A, Hamano H, Uehara T, Kawakami S, Fujita A, Fujinaga Y, Oguchi K, Kawa S, Hanaoka M. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis. Nagoya J Med Sci. 2020；82：101-111.
    doi: 10.18999/nagjms.82.1.101
    (Nagoya Journal of Medical Science. IF:0.897)
  2. Ito M, Yasuo M, Droma Y, Kobayashi N, Hanaoka M.
    Myeloperoxidase (MPO) Gene Polymorphisms are not Associated with Japanese Patients with COPD. Shinshu Med J. 2020；68：41-48.
  3. Niwamoto T, Handa T, Matsui S, Yamamoto H, Yoshifuji H, Abe H,Matsumoto H, Kodama Y, Chiba T, Seno H, Mimori T, Hirai T.
    Phenotyping of　IgG4-related diseases based on affected organ pattern:
    A multicenter cohort study using cluster analysis.
    Modern Rheumatology. 2020；4：1-6．doi:10.1080/14397595.2019.1703522
  4. Droma Y, Kinjo T, Nozawa S, Kobayashi N, Yasuo M, Hanaoka M.
    Vascular endothelial growth factor gene (VEGF) polymorphisms in Sherpa highlanders.
    Japanese Journal of Mountain Medicine. 2020；39：32-37.
  5. Kinjo T, Kitaguchi Y, Droma Y, Yasuo M, Wada Y, Ueno F, Ota M,Hanaoka M. The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients. Sci Rep. 2020；10：12811.
    doi: 10.1038/s41598-020-69184-8. [Epub ahead of print]
  6. Yasuo M, Kitaguchi Y, Tokoro Y, Kosaka M, Wada Y, Kinjo T, Ushiki A, Yamamoto H, Hanaoka M. Differences Between Central Airway Obstruction and Chronic Obstructive Pulmonary Disease Detected with the Forced Oscillation Technique. Int J Chron Obstruct Pulmon Dis.2020；15：1425-1434.　doi: 10.2147/COPD.S246126.
  7. Ikuyama Y, Ushiki A, Kosaka M, Akahane J, Mukai Y, Araki T,Kitaguchi Y, Tateishi K, Urushihata K, Yasuo M, Yamamoto H,
    Hanaoka M. Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: a retrospective single-centre study. BMC Pulm Med. 2020；20：144.　doi: 10.1186/s12890-020-01185-9.
  8. Komatsu M, Yamamoto H, Yasuo M, Ushiki A, Nakajima T, Uehara T,
    Kawakami S, Hanaoka M. The utility of serum C-C chemokine ligand
    1 in sarcoidosis: A comparison to IgG4-related disease. Cytokine.
    2020；133：155123．doi: 10.1016/j.cyto.2020.155123. [Epub ahead of print]
  9. Sonehara K, Tateishi K, Komatsu M, Yamamoto H, Hanaoka M.
    Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer. Thorac Cancer. 2020；11：1578-1586.
    doi: 10.1111/1759-7714.13432．
  10. Imatoh T, Ushiki A, Ota M, Ito M, Sekine A, Yamashita T, Mashimo Y, Nakamura R, Saito K, Saito Y, Hanaoka M. Association of HLA-DRB1*04:05 allele with drug-induced interstitial lung disease in Japanese population. Pharmacogenomics J. 2020；20：823-830.
    doi: 10.1038/s41397-020-0172-3.
  11. Okuma Y, Ko R, Shukuya T, Tateishi K, Imai H, Iwasawa S, Miyauchi E, Kojima T, Fujita Y, Hino T, Yamanda S, Suzuki T, Fukuizumi A, Sakakibara T, Harada T, Morita S, Kobayashi K, Nukiwa T,
    Takahashi K; North East Japan Study Group. Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy. Lung Cancer. 2020；148：122-128.
    doi: 10.1016/j.lungcan.2020.08.014.
Ⅲ.症例報告
  1. Ikuyama Y, Wada Y, Tateishi K, Kitaguchi Y, Yasuo M, Ushiki A, Urushihata K, Yamamoto H, Kamijo H, Mita A, Imamura H, Hanaoka M. Successful recovery from critical COVID-19 pneumonia with extracorporeal membrane oxygenation: A case report. Respir Med Case Rep. 2020；30：　doi: 10.1016/j.rmcr.2020.101113. [Epub ahead of print]

和論文

Ⅰ.著書（単行本・分担執筆）
Ⅱ.論文原著・総説
  1. 林田美江，和田洋典，北口良晃，安尾将法，花岡正幸，瀬山邦明，井上義一，巽　浩一郎．リンパ脈管筋腫症に伴う気胸の再発予防策として胸腔鏡下全胸膜カバリング術は推奨されますか?．日本呼吸器学会誌．2020；9：151-159．
  2. 牛木淳人，花岡正幸．日本人の薬剤性肺障害：概論．呼吸器内科．2020；36：597-603．
  3. 和田洋典，花岡正幸．【特集　第6回世界肺高血圧症学会2018のステートメントを読み解く】血行動態の定義と最新の臨床分類．呼吸器内科．2020；37：238-242．
  4. 山本　洋，小松雅宙，小沢陽子，安尾将法，上原剛，川上　聡，小口和浩，川　茂幸，久保惠嗣，松井祥子．IgG4関連呼吸器疾患．呼吸器内科．2020．38：521-531．
Ⅲ.症例報告
  1. 生山裕一，安尾将法，曽根原圭，平林太郎，後藤憲彦，野沢修平，牛木淳人，山本　洋，花岡正幸．原発不明癌による食道狭窄，気管食道瘻に対し気管ステント，食道ステントを留置し，経口摂取が可能となった１例．気管支学．2020；42：188-192．
Ⅳ.その他
Ⅴ.受賞

内科学第一教室の紹介

< 戻る